Corporate Profile

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North and South America, Europe and Asia Pacific.

Recent Press Releases

April 15, 2014 - 5:00 p.m.
Gilead Sciences to Release First Quarter 2014 Financial Results on Tuesday, April 22, 2014Printer Friendly Version 

Upcoming Events

Tuesday, April 22, 2014 4:15 p.m. ET
Q1 2014 Gilead Sciences Earnings Conference Call
Thursday, May 1, 2014 through Sunday, May 4, 2014
23rd Annual Canadian Conference on HIV/AIDS Research (CAHR)
Saturday, May 3, 2014 through Tuesday, May 6, 2014
Digestive Disease Week (DDW)
Wednesday, May 7, 2014
Gilead Sciences 2014 Annual Shareholder Meeting
Wednesday, May 7, 2014 through Saturday, May 10, 2014
Heart Rhythm Society (HRS)
Tuesday, May 13, 2014 through Thursday, May 15, 2014
Gilead Sciences at Bank of America Merrill Lynch Health Care Conference
Friday, May 16, 2014 through Wednesday, May 21, 2014
American Thoracic Society (ATS)
Monday, May 19, 2014 through Wednesday, May 21, 2014
Gilead Sciences at UBS Global Life Sciences Conference
Friday, May 30, 2014 through Tuesday, June 3, 2014
American Society of Clinical Oncology (ASCO)

Most Viewed Links

Updated 04/20/14
1.Stock Information
2.SEC Filings
3.Annual Reports
4.Proxy Online
5.Fundamentals - Snapshot
* Data collected 04/12/14 - 04/19/14

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
NASDAQ (US Dollar)
$70.00
 Stock is Up 0.72 (1.04%)
Data as of 04/17/14 4:00 p.m. ET
Minimum 20 minute delay
Refresh Quote
Webcast Replay